Table 1.

Clinical features of patients with isolated SMGN

	SMGN (N = 150)
Age, years	41.5 (32.8–51.3)
Male, n (%)	39/150 (26.0)
BUN, mmol/L	4.1 (3.3–6.0)
Serum creatinine, μmol/L	61.0 (50.0–77.1)
Serum albumin, g/L	26.0 (19.5–36.3)
eGFR, mL/min/1.73 m2	107.1 (87.3–120)
Hemoglobin, g/L	135.0±20.8
Serum IgA, g/L	2.2 (1.6–2.8)
Serum IgG, g/L	7.2 (5.1–10.7)
Serum IgM, g/L	1.4 (0.9–2.0)
Serum C3, g/L	1.2±0.3
Urine protein, g/day	3.3 (1.6–5.9)
No. of patients showing microscopic hematuria, %	62/141 (44.0)
No. of patients showing full nephrotic syndrome, %	42/127 (33.1)
No. of patients showing nephrotic range proteinuria, %	54/112 (48.2)
No. of patients showing hypoalbuminemia, %	83/143 (58.0)
Positive ANA, %	25/109 (22.9)
Positive HBsAg, %	7/130 (5.4)
No. of patients showing edema, %	103/139 (74.1)
No. of patients with eGFR<60 mL/min/1.73 m2, %	17/142 (12.0)